Publications

Classer les publications sur l'année

  • Économie de la santĂ©

    L’Ă©valuation mĂ©dico-Ă©conomique : une place qui reste Ă  trouver


    DETOURNAY B

    La Lettre du CollĂšge ; 2012;2:5-7

  • Économie de la santĂ©

    Insulin therapy for diabetes mellitus: Treatment regimens and associated costs

    CHARBONNEL B, PENFORNIS A, VARROUD-VIAL M, KUSNIK-JOINVILLE O, DETOURNAY B

    Diabetes Metab ; 2012;38:156-163

  • Pharmaco-EpidĂ©miologie

    Feasibility and acceptability of rapid HIV test screening (DEPIVIH) by French family physicians

    GAUTHIER R, LIVROZET JM, PREVOTEAU DU CLARY F, TAULERA O, BOUEE S, AUBERT JP, PY AM , PETER JM, MAJERHOLC C, HÉBER SUFFRIN S, COMPAGNON C, WAJSBROT  A

    Med Mal Infect ; 2012;42:553-560

  • SantĂ© publique

    Evaluer les activitĂ©s d’Ă©ducation thĂ©rapeutique : pourquoi ? Pour qui ?

    DETOURNAY B

    Education Thérapeutique : L'Evaluation ; 2012;8-12

  • Pharmaco-EpidĂ©miologie

    ESPERA study : Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice

    DE TOFFOL B, DE ZELICOURT M, VESPIGNANI H, FAGNANI F, LAURENDEAU C, LEVY-BACHELOT L, MURAT C, GASALLA T, ARZIMANOGLOU A, VILLANUEVA V

    Epilepsy Behav ; 2012;25(2):166-169

  • Pharmaco-EpidĂ©miologie

    Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe study

    SPIELMANN M, LUPORSI E, RAY-COQUARD I, DE BOTTON S, AZRIA D, LASOCKI S, LAFUMA A, MAHI L, DERAY G, BUGAT R
    A, MAHI L, DERAY G, BUGAT R

    Eur J Cancer ; 2012;48(1):101-107

  • Pharmaco-EpidĂ©miologie

    Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient : a prospective, randomised study

    DAHAN E, BEN SIMON GJ, LAFUMA A

    Eye ; 2012;26(5):703-710

  • Pharmaco-EpidĂ©miologie

    Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes

    DETOURNAY B, SIMON D, GUILLAUSSEAU PJ, JOLY D, VERGES B, ATTALI C, CLEMENT O, BRIAND Y, DELAITRE O

    Diabetes Metab ; 2012;38:102-112

  • Pharmaco-EpidĂ©miologie

    An observational study of the initial management of hypothyroidism in France : the ORCHIDEE Study

    DELEMER B, AUBERT JP, NYS P, LANDRON F, BOUEE S

    Eur J Endocrinol ; 2012;167:817-823

  • Pharmaco-EpidĂ©miologie

    A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: The AVANCE study

    HALIMI S, AUBERT JP, FONTBONNE A, GUILLAUSSEAU PJ, NACHIT F, BOUEE S, DETOURNAY B

    Diabetes Metab ; 2012;38:343-351

  • Pharmaco-EpidĂ©miologie

    Traitements antidiabĂ©tiques des patients diabĂ©tiques de type 2 atteints d’une insuffisance rĂ©nale modĂ©rĂ©e ou sĂ©vĂšre suivis en mĂ©decine gĂ©nĂ©rale en France

    BOUEE S, GAUDIN AF, AMELINEAU E, BONNET F

    Thérapie ; 2013;68(1):19-26

  • Économie de la santĂ©

    The association between asthma control, health care costs, and quality of life in France and Spain

    DOZ M, CHOUAID C, COM-RUELLE L, CALVO E, BROSA M, ROBERT J, DECUYPERE L, PRIBIL C, HUERTA A, DETOURNAY B

    BMC Pulm Med ; 2013;22:13-15

  • Économie de la santĂ©

    Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study

    VILLANUEVA V, GIRÓN JM, MARTÍN J, HERNÁNDEZ-PASTOR LJ, LAHUERTA J, DOZ M, CUESTA M, LÉVY-BACHELOT L; INVESTIGADORES DEL ESTUDIO ESPERA

    Neurologia ; 2013;28(4):195-204

  • Économie de la santĂ©

    Le reste à charge des patients diabétiques en France en 2007

    DETOURNAY B, ROBERT J, GADENNE S

    BEH ; 2013;37-38:471-476

  • Économie de la santĂ©

    L’évaluation mĂ©dico-Ă©conomique des produits de santĂ© dans le contexte de la loi de financement de la SĂ©curitĂ© sociale pour 2012

    DERVAUX B, BASEILHAC E, FAGON JY,  AMEYE V, ANGOT P, AUDRY A, BECQUEMONT L, BOREL T,CAZENEUVE B, COURTOIS J, DETOURNAY B, FAVRE P, et al

    Thérapie ; 2013;68(4):253-257